Cognex (NASDAQ:CGNX) Announces Earnings Results, Beats Estimates By $0.09 EPS

06 May 2026, 19:42 by Amy Steele · The Cerbat Gem

Cognex (NASDAQ:CGNX – Get Free Report) announced its earnings results on Wednesday. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.25 by $0.09, FiscalAI reports. Cognex had a net margin of 11.51% and a return on equity of 9.02%. The firm had revenue of $268.44 million for the quarter, compared to analyst estimates of $245.98 million. Cognex updated its Q2 2026 guidance to 0.400-0.440 EPS.

Cognex Stock Up 5.8%

CGNX traded up $3.43 during midday trading on Wednesday, hitting $62.26. 6,817,557 shares of the company were exchanged, compared to its average volume of 2,124,689. The firm has a market capitalization of $10.40 billion, a P/E ratio of 92.93 and a beta of 1.48. The firm’s 50 day moving average price is $52.39 and its 200-day moving average price is $44.95. Cognex has a 1-year low of $27.82 and a 1-year high of $63.01.

Cognex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 12th. Stockholders of record on Thursday, February 26th were paid a dividend of $0.085 per share. The ex-dividend date of this dividend was Thursday, February 26th. This represents a $0.34 annualized dividend and a dividend yield of 0.5%. Cognex’s dividend payout ratio (DPR) is presently 50.75%.

Insider Activity at Cognex

In other Cognex news, Director Robert Willett sold 177,052 shares of the stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $58.39, for a total transaction of $10,338,066.28. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Laura Ann Macdonald sold 14,881 shares of the stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $57.16, for a total value of $850,597.96. Following the transaction, the vice president owned 2,212 shares in the company, valued at $126,437.92. The trade was a 87.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 196,083 shares of company stock worth $11,419,321 over the last quarter. Company insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On Cognex

A number of large investors have recently bought and sold shares of the stock. Geneos Wealth Management Inc. grew its stake in Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock valued at $27,000 after acquiring an additional 736 shares during the period. CIBC Private Wealth Group LLC grew its stake in Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock valued at $35,000 after acquiring an additional 327 shares during the period. Caitong International Asset Management Co. Ltd acquired a new stake in Cognex in the fourth quarter valued at approximately $39,000. Meeder Asset Management Inc. acquired a new position in shares of Cognex during the fourth quarter valued at about $47,000. Finally, Wexford Capital LP bought a new stake in shares of Cognex during the third quarter worth about $52,000. 88.12% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Cognex

Here are the key news stories impacting Cognex this week:

Positive Sentiment: Q1 results beat expectations — Cognex reported $0.34 EPS vs. $0.25 consensus and revenue of $268.4M vs. $246.0M consensus, with improved margins. The print demonstrates demand resilience and drove the initial upside. Cognex Reports First Quarter 2026 Results
Positive Sentiment: Management raised Q2 guidance well above Street estimates — EPS guidance of $0.400–$0.440 (vs. $0.300 consensus) and revenue guidance of $280M–$300M (vs. ~$269M consensus), signaling continued growth and margin visibility. This guidance lift is a key catalyst for the stock jump. Cognex Q1 Press Release / Guidance
Positive Sentiment: New product & partner news bolsters AI/edge roadmap — Cognex launched the In-Sight® 3900, a high-performance embedded AI vision system powered by Qualcomm, which expands addressable markets for edge inspection without an external PC. Product/partnership news supports longer-term revenue and AI positioning. Cognex Launches In-Sight 3900
Positive Sentiment: Coverage highlighting AI strategy and momentum — industry/market write-ups are emphasizing Cognex’s AI vision push and strong Q1, which can attract momentum and investor interest. Cognex Posts Strong Q1 Results and Boosts AI Vision
Neutral Sentiment: Valuation and analyst commentary — recent articles assess CGNX’s valuation after the rally; the stock trades at a high P/E relative to history, so further upside may depend on continued execution against raised guidance. Investors should weigh growth vs. current multiple. Assessing Cognex Valuation

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CGNX shares. JPMorgan Chase & Co. upgraded shares of Cognex from an “underweight” rating to a “neutral” rating and set a $55.00 target price on the stock in a research report on Monday, March 9th. Wall Street Zen lowered shares of Cognex from a “buy” rating to a “hold” rating in a research report on Saturday, April 11th. KeyCorp restated an “overweight” rating and set a $70.00 target price (up from $50.00) on shares of Cognex in a research report on Friday, February 13th. Raymond James Financial restated a “strong-buy” rating on shares of Cognex in a research report on Thursday, February 12th. Finally, UBS Group restated a “buy” rating and set a $70.00 target price on shares of Cognex in a research report on Friday, February 13th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $59.50.

Check Out Our Latest Report on Cognex

Cognex Company Profile

(Get Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.